Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
70.92
-6.08 (-7.90%)
At close: Apr 28, 2026, 4:00 PM EDT
71.41
+0.49 (0.70%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $231.82 million as of April 28, 2026. Its market cap has increased by 1,933.51% in one year.
Market Cap
231.82M
Enterprise Value
208.81M
1-Year Change
1,933.51%
Ranking
Category
Stock Price
$70.92
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $231.82M, an increase of 1.54%. That is a compound annual growth rate of 0.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 214.50M | 82.71% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 255.08M |
| SAB Biotherapeutics | 247.37M |
| Arcturus Therapeutics Holdings | 244.15M |
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.69M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |